Occurrence and Risk of Cochleotoxicity in Cystic Fibrosis Patients Receiving Repeated High-Dose Aminoglycoside Therapy

Cystic fibrosis (CF) patients receive repeated courses of aminoglycoside therapy. These patients would consequently be expected to be more susceptible to cochleotoxicity, a recognized side effect with single courses of aminoglycoside therapy. The primary aim of this retrospective study was to establ...

全面介紹

書目詳細資料

發表在:	Antimicrob Agents Chemother
Principais autores:	Mulheran, M., Degg, C., Burr, S., Morgan, D. W., Stableforth, D. E.
格式:	Artigo
語言:	Inglês
出版:	American Society for Microbiology (ASM) 2001
主題:	Clinical Therapeutics
在線閱讀:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90684/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11502521/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.9.2502-2509.2001
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!